Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
Evergreen Novartis
The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy
Novartis loses patent appeal in landmark suit
Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …